feed,title,long_url,short_url
MarketWatch,Biogen says ALS drug did not meet primary endpoint in Phase 3 clinical trial,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/nF5TJ4lNvtU/story.aspx,https://on.mktw.net/3mYBY98
